| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1763f7f78d01cad638210d060676591a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-088 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-08 |
| filingDate |
1998-04-30^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2002-01-15^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2abdffa1beb0e680a83792575fd5eb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_387f348e07615f525442f50e8204f073
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1e45d62f2601cbd6d7e168db360c50c |
| publicationDate |
2002-01-15^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-6338834-B1 |
| titleOfInvention |
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma |
| abstract |
A compound for use as a diagnostic or therapeutic pharmaceutical and method of using the same where the compound consists essentially of an alpha-melanotropin stimulating hormone analog which has integrally located a radionuclide. The radionuclide is administered to the body in an amount sufficient to allow uptake and retention by the tumor cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8278111-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046493-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6680045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7807143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10729669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1913959-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008046493-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8975082-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596613-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009060868-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8758770-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011059891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9187735-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023091689-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11179484-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11576987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529335-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096652-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012177579-A1 |
| priorityDate |
1998-04-30^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |